BioCardia, Inc.

Contributing Author

Recent Articles by BioCardia, Inc.

Aug-06	BioCardia to Host Q2 2025 Corporate Update and Financial Results Conference Call on August 11, 2025 BCDA GlobeNewswire
Aug-04	BioCardia Provides Update on Timing of Regulatory Activities Seeking FDA Approval and Japan PMDA Approval for CardiAMP Cell Therapy for Heart Failure and Helix Transendocardial Delivery Catheter BCDA GlobeNewswire
Jul-24	BioCardia Submits Request for Clinical Data Review Meeting with Japan PMDA To Discuss Approval Pathway for CardiAMP Cell Therapy in Ischemic Heart Failure BCDA GlobeNewswire
Jul-16	Henry Ford Health Initiates Patient Enrollment for BioCardia's CardiAMP HF II Pivotal Study for Ischemic Heart Failure of Reduced Ejection Fraction BCDA GlobeNewswire
Jun-25	BioCardia Announces New United States Patent for Helix Biotherapeutic Delivery System BCDA GlobeNewswire
May-21	BioCardia to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21, 2025 BCDA GlobeNewswire
May-14	BioCardia Reports First Quarter 2025 Business Highlights and Financial Results BCDA GlobeNewswire
May-09	BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025 BCDA GlobeNewswire
May-06	BioCardia Initiates Patient Enrollment at University of Wisconsin at Madison for Ongoing CardiAMP HF II Pivotal Study BCDA GlobeNewswire
May-01	BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial of the Company's Lead Cell Therapy for Treatment of Heart Failure BCDA GlobeNewswire